Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279369 · ClinicalTrials.gov registry record
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
A clinical trial, sponsored by Winthrop University Hospital.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01279369: Clinical Trial study, sponsored by Winthrop University Hospital.
NCT01279369 is a clinical trial that was terminated before completion, run by Winthrop University Hospital. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01279369 was terminated before completion, sponsored by Winthrop University Hospital.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the presence of fetal fibronectin in the cervicovaginal secretions of pregnant patients with minor maternal trauma predicts impending preterm delivery due to abruptio placenta.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-10 |
Why NCT01279369 stopped before completion
NCT01279369 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01279369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01279369 about?
NCT01279369 is a clinical study titled "The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta". The purpose of this study is to determine if the presence of fetal fibronectin in the cervicovaginal secretions of pregnant patients with minor maternal trauma predicts impending preterm delivery due to abruptio placenta.
What is the current status of trial NCT01279369?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2009-10. Estimated completion is 2012-10.
Who is sponsoring clinical trial NCT01279369?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia